Sign Up Today and Learn More About Obie Stock
Invest in or calculate the value of your shares in Obie or other pre-IPO companies through EquityZen's platform.

Obie Stock (OBIE)
Obie is an insurtech startup that offers insurance and risk management for real estate investors.
About Obie Stock
Founded
2017
Headquarters
Chicago, IL, US
Industries
Financial Services, Real Estate
Obie is an insurtech startup that offers insurance and risk management for real estate investors. It aims to provide a simple, affordable, and transparent experience for clients and their investment properties. Its technology guarantees industry-best rates for the property and casualty plans that are right for clients, ensuring that they, and their investments, are protected. Obie is now available to landlords and property investors in all 50 states.
Obie Press Mentions
Stay in the know about the latest news on Obie
Obie Unveils New Brand to Move Real Estate Investment Insurance Forward
coverager • Apr 02, 2025
Obie Introduces PolicyProof: Simplifying Property Manager Insurance Compliance with Built-In Liability Protection
coverager • Jan 22, 2025
Doorvest acquires Rubik
coverager • Jan 16, 2025
Obie Expands Embedded Insurance Integration Across Digital Platforms, Now Supporting Salesforce Experience Cloud
coverager • Dec 03, 2024
Obie Unveils Tenant Legal Liability Policy to Empower Real Estate Investors with Streamlined Tenant Risk Coverage
businesswire • Nov 15, 2024
Obie Management
Leadership team at Obie
CEO and Co-Founder
Ryan Letzeiser
Head of Marketing
Nate Smoyer

Join now and verify your accreditation status to gain access to:
- Obie Current Valuation
- Obie Stock Price
- Obie Management
- Available deals in Obie and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Obie Cap Table and Funding History by Share Class and Liquidity Preferences
- Obie Revenue and Financials
- Obie Highlights
- Obie Business Model
- Obie Risk Factors
- Obie Research Report from SACRA Research
Trading Obie Stock
How to invest in Obie stock?
Accredited investors can buy pre-IPO stock in companies like Obie through EquityZen funds. These investments are made available by existing Obie shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Obie stock?
Shareholders can sell their Obie stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."